Search

Author/Creator Juan‐Vidal, Oscar

1. ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin‐bound paclitaxel with or without CC‐486 as second‐line treatment for advanced nonsquamous non‐small cell lung cancer (NSCLC). Issue 24 (1st November 2018)

Authors:
Morgensztern, Daniel; Cobo, Manuel; Ponce Aix, Santiago; Postmus, Pieter E.; Lewanski, Conrad R.; Bennouna, Jaafar; Fischer, Jürgen R.; Juan‐Vidal, Oscar; Stewart, David J.; Fasola, Gianpiero; Ardizzoni, Andrea; Bhore, Rafia; Wolfsteiner, Marianne; Talbot, Denis C.; Jin Ong, Teng; Govindan, Ramas...
Journal:
Cancer
Issue:
Volume 124:Issue 24(2018)
Page Start:
4667
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. RESILIENT part 1: a phase 2 dose‐exploration and dose‐expansion study of second‐line liposomal irinotecan in adults with small cell lung cancer. Issue 9 (23rd February 2022)

Authors:
Paz‐Ares, Luis; Spigel, David R.; Chen, Yuanbin; Jove, Maria; Juan‐Vidal, Oscar; Rich, Patricia; Hayes, Theresa; Calderón, Vanesa Gutiérrez; Caro, Reyes Bernabe; Navarro, Alejandro; Dowlati, Afshin; Zhang, Bin; Moore, Yan; Yao, Xiaopan; Kokhreidze, Jaba; Ponce, Santiago; Bunn, Paul A.
Journal:
Cancer
Issue:
Volume 128:Issue 9(2022)
Page Start:
1801
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search